Sanofi India, a company working in the pharmaceutical sector, has made a big announcement for its investors. Notably, the board of directors of the pharma company—which is part of the BSE 1000 index—in its meeting held on February 25, 2026, recommended a final dividend of 480 percent for the financial year ending December 31, 2025. The company gave this information in its regulatory filing on the stock exchange.
When is the record date?
The company announced a final dividend of 480 percent for the financial year ending December 31, 2025; This means investors will get ₹48 for every share they hold, which is based on the face value of ₹10 per share. The record date for this dividend has been fixed as April 22. This means that only those investors, whose names appear in the register of the company by this date, will be entitled to benefit from the dividend. The ex-dividend date for this payment is also 22nd April. Therefore, eligible investors must buy shares of Sanofi India before this date. It is worth noting that Sanofi India has an excellent track record of consistently paying dividends to its shareholders. In 2025, the company distributed cash rewards on two occasions—₹75 in November and ₹117 in April. In 2024, Sanofi India declared dividends twice—₹117 in May and ₹50 in March.
What does the company do?
Sanofi India is a well-known R&D-based pharmaceutical company, established in 1956. The company has expertise in therapeutic areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Vaccines. As a subsidiary of France-based Sanofi, the company has a strong manufacturing presence in Goa. Furthermore, its product portfolio includes a wide range of high quality products, including popular brands like Lantus, Combiflam and Allegra.
